{"nct_id":"NCT00823719","title":"Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)","status":"COMPLETED","status_verified_date":"2013-02","start_date":"2009-05","start_date_type":null,"primary_completion_date":"2011-07","primary_completion_date_type":"ACTUAL","completion_date":"2011-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}